Post by peryannie4 on Apr 28, 2022 8:27:09 GMT -5
The FDA approved Erlotinib in 2004 to treat patients who suffer from metastatic non-small cell lung cancer; those tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations and locally advanced, unresectable, or metastatic pancreatic cancer. Erlotinib reversibly inhibits the kinase activity of EGFR, preventing autophosphorylation of tyrosine residues associated with the receptor and thereby inhibiting further downstream signaling. Erlotinib binding affinity for EGFR exon 19 deletion or exon 21 (L858R) mutations is higher than its affinity for the wild-type receptor. The drug comes in the form of tablets in 100 mg and 150 mg to administer orally. One should store this medication at 25°C (77°F); excursions are permitted to 15°C - 30°C (or 59°F - 86°F).
Erlotinib tablets price in India is budget-friendly, and this medication is found with many certified generic medicine suppliers. To know more about Erlotinib tablets, call us via the toll-free no. 18008891064.
Erlotinib tablets price in India is budget-friendly, and this medication is found with many certified generic medicine suppliers. To know more about Erlotinib tablets, call us via the toll-free no. 18008891064.